Meta Pixel

News and Announcements

Kinesis surpasses 59,000 KVTs sold and new partnerships announced

  • Published December 18, 2018 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

KEY TAKEAWAYS:

  • In November, Kinesis surpassed 59,000 KVTs sold.
  • Kinesis appointed two new members of staff, Nigel Owens as Chief Technology Officer and Patrick Davis as General Counsel.
  • The company announced an expanded Memorandum of Understanding (MOU) with Jakarta Futures Exchange.
  • Kinesis have partnered with TicketSocket a highly customizable white label ticketing, registration and event management platform.

In November, Kinesis surpassed 59,000 KVTs sold. KVTs are currently for sale to the public at USD1,000/KVT.

The company announced an expanded Memorandum of Understanding (MOU) with Jakarta Futures Exchange.

The partnership will seek to develop an Indonesian based and regulated blockchain exchange using Kinesis technology.

The expanded partnership between JFX, Kinesis and ABX envisions an Indonesian blockchain exchange based on the technical advances of the Kinesis Blockchain Exchange.

Kinesis have partnered with TicketSocket a highly customizable white label ticketing, registration and event management platform.

This partnership will see Kinesis currencies integrated as a payment option within the TicketSocket platform.

Kinesis releases the MVP demo for the Kinesis Currency Exchange and Kinesis eWallet.

This demo environment allows users to create their own eWallets, mint their own Kinesis currencies (KAU = gold and KAG = silver) through the Kinesis Currency Exchange (KCX), emit these currencies into their wallets and then send the currencies to other wallets on the Kinesis Blockchain.

All the steps can be found here: https://kinesis.money/en/mvp-demo/

Kinesis have appointed two new staff members, Nigel Owens as Chief Technology Officer and Patrick Davis as General Counsel.

Nigel has over 16 years of extensive executive management experience in delivering both IT and business transformational change within the financial services sector and commodities market.

Whilst at the London Metal Exchange he led the technology transformation which enabled the Exchange to move from a trading capacity of circa €2 trillion per annum in 2008 to over €16 trillion per annum by the end of 2014.

Patrick has more than 20 years of legal experience in OTC, exchange traded and cleared financial and commodity markets, and related data and benchmark space.

Patrick most recently worked for 15 years as Head of Legal for the IntercontinentalExchange (ICE) UK Group companies, including the regulated entities, ICE Futures Europe, ICE Clear Europe Limited and ICE Benchmark Administration Limited.

 

About Kinesis Monetary System

The vision for Kinesis is to deliver an evolutionary step beyond any monetary system available today. This is achieved by basing the Kinesis currencies 1:1 on allocated physical gold and silver. Use is incentivised by attaching a unique yield system to the Kinesis currencies and distributing back the wealth generated according to proportionate currency holdings and velocity.

Register Interest

Capital Insights
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship

From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now